Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist/1st communication: Antihypertensive effects of valsartan in hypertensive models

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 5, 1997, Pages 604-612

  Yamamoto, Shigeru ^a   Hayashi, Naoyuki ^a   Kometani, Motohiko ^a   Nakao, Kenzo ^a   Inukai, Toshiya ^a  

^a CIBA GEIGY LTD   (Switzerland)

Author keywords

Angiotensin II receptor antagonists; CAS 137862 53 4; CGP 48933, antihypertensive effect; Enalapril; Hypertension, experimental, renal, spontaneous; Valsartan

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ENALAPRIL; VALSARTAN;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; DOG; DRUG EFFECT; DRUG RECEPTOR BINDING; HYPERTENSION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

ALDOSTERONE; ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DESOXYCORTICOSTERONE; DOGS; ENALAPRIL; HEART RATE; HYPERTENSION; HYPERTENSION, RENAL; MALE; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RENIN; TETRAZOLES; VALINE;

EID: 0030995342     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Williams, G. H., New Engl. J. Med. 319, 1517 (1988)
2. McAreavey, D., Robertson, J. I. S., Drugs 40, 326 (1990)
3. Erdoes, E. G., Skidgel, R. A., Hypertension 8 (Suppl. I), I-34 (1986)
4. Erdoes, E. G., Hypertension 16, 363 (1990)
5. Subissi, A., Guelfi, M., Criscuoli, M., Br. J. Pharmacol. 100, 502 (1990)
6. Alderman, C. P., Ann. Pharmacother. 30, 55 (1996)
7. Shiota, N., Okunishi, H., Fukamizu, A., FEBS Lett. 323 239 (1993)
8. Urata, H., Boehm, K. D., Philip, A., J. Clin. Invest. 91, 1269 (1993)
9. The Multicenter European Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Colonary Obstruction Restenosis (MERCATOR) Study Group, Circulation 86, 100 (1992)
10. Criscione, L., de Gasparo, M., Buehlmayer, P., Br. J. Pharmacol. 110, 761 (1993)
11. Wong, P. C., Price, W. A., Chiu, A. T., J. Pharmacol. Exp. Ther. 255, 211 (1990)
12. Criscione, L., Bradley, W. A., Buelmayer, P., Cardiovsc. Drug Rev. 13, 230 (1995)
13. Ohmura, I., Maki, E., Naruse, T., Folia Pharmacol. Japon. 86, 293 (1985)
14. Tanaka, M., Yamamoto, S., Nakao, K., Arzneim.-Forsch./Drug Res. 41, 608 (1991)
15. Wong, P. C., Price, W. A., Chiu, A. T., J. Pharmacol. Exp. Ther. 252, 726 (1990)
16. Wong, P. C., Price, W. A., Chiu, A. T., Hypertension 15, 459 (1990)
17. Pettinger, W. A., Marchelle, M., Augusto, L., Am. J. Physiol. 221, 1071 (1971)
18. Sato, Y., Fujita, T., Yamashita, K., Folia Pharmacol. Japon. 82, 117 (1983)
19. Ohmura, I., Maki, E., Naruse, T., Folia Pharmacol. Japon. 86, 303 (1985)
20. Sweet, C. S., Arbegast, P. T., Gaul, S. L., Eur. J. Pharmacol. 76, 167 (1981)
21. Nishimura, K., Miyazaki, M., Okunishi, H., Japan. J. Pharmacol. 43, 379 (1987)
22. Oda, M., Suzuki, K., Ino, Y., Folia Pharmacol. Japon. 93, 235 (1989)
23. Hamada, K., Nakajima, Y., Nirei, H., Japan. J. Pharmacol. 63, 335 (1993)
24. Bunkenburg, B., Schnell, C., Baum, H. P., Hypertension 18, 278 (1991)
25. Wong, P. C., Price, W. A., Chui, A. T., Am. J. Hypertens. 4, 288S (1991)
26. Mizuno, K., Niimura, S., Tani, M., Eur. J. Pharmacol. 215, 305 (1992)
27. Mizuno, K., Niimura, S., Tani, M., Life. Sci. 50, 183 (1992)
28. Laffan, R. J., Goldberg, M. E., High, J. P., J. Pharmacol. Exp. Ther. 204, 281 (1978)
29. Dzau, V. J., Circulation 77 (Suppl. I), I-4 (1988)
30. Keeton, T. K., Campbell, W. B., Pharmacol. Rev. 31, 81 (1981)
31. Chang, R. S. L., Lotti, V. J., Molecular Pharmacol. 29, 347 (1990)